Access cutting-edge macular degeneration treatment through this clinical trial at a research site in Melbourne. Study-provided care at no cost to qualified participants.
Access macular degeneration specialists in Melbourne at no cost
This study follows strict safety protocols and ethical guidelines
All study-related macular degeneration treatment provided free
Phase 1/2 dose-escalation and randomized, controlled, masked expansion trial in adults with wet AMD undergoing active anti-VEGF treatment. Substudies will evaluate the safety and tolerability of 4D-150 contralateral eye dosing and characterize vector shedding.
Sponsor: 4D Molecular Therapeutics
Check if you qualify for this macular degeneration clinical trial in Melbourne, FL
If you're searching for macular degeneration treatment options in Melbourne, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Melbourne research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.